Andreasson U

References (4)

Title : Pre-analytical stability of novel cerebrospinal fluid biomarkers - Willemse_2019_Clin.Chim.Acta_497_204
Author(s) : Willemse EAJ , Vermeiren Y , Garcia-Ayllon MS , Bridel C , De Deyn PP , Engelborghs S , van der Flier WM , Jansen EEW , Lopez-Font IB , Mendes V , Manadas B , de Roeck N , Saez-Valero J , Struys EA , Vanmechelen E , Andreasson U , Teunissen CE
Ref : Clinica Chimica Acta , 497 :204 , 2019
Abstract :
PubMedSearch : Willemse_2019_Clin.Chim.Acta_497_204
PubMedID: 31348908

Title : Reduced cerebrospinal fluid concentration of interleukin-12\/23 subunit p40 in patients with cognitive impairment - Johansson_2017_PLoS.One_12_e0176760
Author(s) : Johansson P , Almqvist EG , Wallin A , Johansson JO , Andreasson U , Blennow K , Zetterberg H , Svensson J
Ref : PLoS ONE , 12 :e0176760 , 2017
Abstract :
PubMedSearch : Johansson_2017_PLoS.One_12_e0176760
PubMedID: 28464009

Title : Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease - Johansson_2013_PLoS.One_8_e81989
Author(s) : Johansson P , Almqvist EG , Johansson JO , Mattsson N , Andreasson U , Hansson O , Wallin A , Blennow K , Zetterberg H , Svensson J
Ref : PLoS ONE , 8 :e81989 , 2013
Abstract :
PubMedSearch : Johansson_2013_PLoS.One_8_e81989
PubMedID: 24312390

Title : Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease - Parnetti_2011_Acta.Neurol.Scand_124_122
Author(s) : Parnetti L , Chiasserini D , Andreasson U , Ohlson M , Huls C , Zetterberg H , Minthon L , Wallin AK , Andreasen N , Talesa VN , Blennow K
Ref : Acta Neurologica Scandinavica , 124 :122 , 2011
Abstract :
PubMedSearch : Parnetti_2011_Acta.Neurol.Scand_124_122
PubMedID: 20880294